GLA
GPCR icon

Good Life Advisors’s Structure Therapeutics GPCR Stock Holding History

Good Life Advisors’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$311K Buy
15,000
+2,000
+15% +$44K 0.02% 395
2025
Q1 		$225K Buy
+13,000
New +$318K 0.02% 453

Other funds holding GPCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Good Life Advisors's GPCR Position: Q2 2025 in Review

Good Life Advisors increased its Structure Therapeutics (GPCR) stake by 15% in Q2 2025, buying an estimated $44K and bringing the position to 15,000 shares worth $311K. The position accounts for 0.02% of the portfolio, ranked #395.

Good Life Advisors first reported a position in GPCR in Q1 2025 and has held it in 2 quarters since. 172 funds tracked by Wall St. Rank hold GPCR as of Q2 2025.

  • Good Life Advisors held 15,000 shares of Structure Therapeutics worth $311K as of Q2 2025.
  • Good Life Advisors bought 2,000 Structure Therapeutics shares in Q2 2025, an estimated $44K.
  • Structure Therapeutics made up 0.02% of Good Life Advisors's portfolio in Q2 2025, its #395 holding.
  • Good Life Advisors first reported a position in Structure Therapeutics in Q1 2025 and has held it in 2 quarters since.
  • 172 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2025.

Based on Good Life Advisors's 13F filing for Q2 2025, filed 8 Aug 2025.